Back to List

Regenerative Medicinal Products Act - Article 3

Regenerative Medicinal Products Act｜第 3 條｜Food and Drug Administration｜Act｜In Force

衛生福利部｜v1.0

Effective Date: 2026-01-01｜Last Amended: 2024-06-19

Content

Regenerative medicinal products referred to in this Act mean drugs for human use that contain genes, cells, and cell derivatives thereof. The regenerative medicinal products mentioned in the preceding paragraph are classified as drugs under Article 6 of the Pharmaceutical Affairs Act.

Related Regulations - Regenerative Medicinal Products Act

• Medical Devices Act - Article 71（第 71 條）
• Regenerative Medicinal Products Act - Article 21（第 21 條）
• Regenerative Medicinal Products Act - Article 1（第 1 條）
• Regenerative Medicinal Products Act - Article 2（第 2 條）
• Regenerative Medicinal Products Act - Article 4（第 4 條）
• Regenerative Medicinal Products Act - Article 5（第 5 條）
• Regenerative Medicinal Products Act - Article 6（第 6 條）